scispace - formally typeset
C

Christopher J. Scarlett

Researcher at University of Newcastle

Publications -  200
Citations -  16054

Christopher J. Scarlett is an academic researcher from University of Newcastle. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 44, co-authored 188 publications receiving 12003 citations. Previous affiliations of Christopher J. Scarlett include Information Technology University & University of Sydney.

Papers
More filters
Journal ArticleDOI

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey, +128 more
- 03 Mar 2016 - 
TL;DR: Detailed genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-β, WNT, NOTCH, ROBO/SLIT signalling, G1/S transition, SWI-SNF, chromatin modification, DNA repair and RNA processing.
Journal ArticleDOI

Whole genomes redefine the mutational landscape of pancreatic cancer.

Nicola Waddell, +88 more
- 26 Feb 2015 - 
TL;DR: Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency, and 4 of 5 individuals with these measures of defective DNA maintenance responded to platinum therapy.
Journal ArticleDOI

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin, +140 more
- 15 Nov 2012 - 
TL;DR: It is found that frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, are also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement ofAxon guidance genes in pancreatic carcinogenesis.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

Whole-genome landscape of pancreatic neuroendocrine tumours

Aldo Scarpa, +129 more
- 02 Mar 2017 - 
TL;DR: In this paper, the authors performed whole-genome sequencing of 102 primary pancreatic neuroendocrine tumours and defined the genomic events that characterize their pathogenesis, including a deficiency in G:C,>T:A base excision repair due to inactivation of MUTYH, which encodes a DNA glycosylase.